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Introduction
In transfusional iron overload, almost all the excess iron
is sequestered intracellularly as ferritin iron, a dispersed,
soluble and rapidly mobilizable fraction, and hemosiderin
iron, an aggregated, insoluble fraction that is a long-term
reserve. The effective transverse relaxation rate (R2*) of
myocardium is predominantly influenced by hemosi-
derin iron and, even with intensive iron-chelating ther-
apy, changes only slowly over several months [1].
Intracellular ferritin iron is evidently in equilibrium with
the low molecular weight cytosolic iron pool [2] that can
decrease rapidly with iron chelation. We propose to use a
new breath-hold fast spin-echo (FSE) [3] pulse sequence
that permits calculation of RR2 [4], a "reduced transverse
relaxation rate" as a measure of myocardial ferritin iron
that is largely independent of hemosiderin iron.
Purpose
To use RR2 measurements to detect short-term changes in
myocardial ferritin iron produced by iron-chelating ther-
apy.
Methods
We imaged 10 patients with thalassemia major (New
York; mean age = 26.9 ± 10.3 years) on a 1.5 T MR scanner
(Siemens-Avanto), and another 8 patients with tha-
lassemia (Hong Kong; mean age = 29.3 ± 8.6 years) on a
3 T scanner (Phillips-Achieva). Both sets of patients were
imaged in a mid-ventricular short-axis plane of the heart
at mid-diastole, initially after discontinuing iron-chela-
tion for one week, and subsequently after resuming their
usual therapy (group 1: deferasirox; group 2: deferoxam-
ine and/or deferiprone), for one week. Three different sets
of FSE data were acquired in separate breath-holds with
different echo spacings (ESP). For details on the pulse
sequence and its parameters, please see references [3,5]. A
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standard R2* mapping pulse sequence was also per-
formed.
For data analysis, the septum was segmented manually.
R2* was calculated by non-linear least square fitting of the
mono-exponential relaxation curve. The RR2 was calcu-
lated by non-linear least square fitting of the three sets of
non-monoexponential relaxation curves with different
ESPs [6].
Results
Figure 1 shows R2* and RR2 maps of a patient after one
week off and thereafter one week on iron chelation. In
both groups (Table 1), the mean RR2 was significantly
decreased on compared to off iron-chelating therapy
(group1: 22.0 ± 5.3 s-1 vs. 24.5 ± 4.9 s-1; p < 0.01; group 2:
20.0 ± 5.6 s-1 vs. 22.1 ± 5.4 s-1; p < 0.01), whereas R2* was
not different between the two states (group1: 61.1 ± 30.6
s-1 vs. 62.3 ± 27.6 s-1; group 2: 71.9 ± 43.3 s-1 vs. 74.1 ±
39.0 s-1).
Conclusion
This study demonstrates that a decrease in myocardial fer-
ritin iron can be detected after as little as one week of iron-
chelating therapy. Measurement of RR2 may provide a
new means of rapidly monitoring the effectiveness of
iron-chelating therapy.
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Table 1: R2* and RR2 values of two groups after 1 week off and thereafter 1 week on iron chelation
Group R2* (1/s) Difference in R2* (1/s) RR2 (1/s) Difference in RR2 (1/s)
Off On Off-On Off On Off-On
1 62.3 ± 27.6 61.1 ± 30.6 1.2 ± 7.8 24.5 ± 4.8 22.0 ± 5.3 2.5 ± 1.8
2 74.1 ± 39.0 71.9 ± 43.3 2.2 ± 9.9 22.1 ± 5.4 20.0 ± 5.6 2.0 ± 2.2Page 2 of 2
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